Insider transactions

Luke Evnin

CIK 1134657 · Chief Executive Officer · last filed 2026-07-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$538.77M
Companies
21
Total Filings
108
Lifetime Open-Market Net
-$55.10M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

PCRX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
399 BOYLSTON STREET
SUITE 1100
BOSTON, MA 02116
Related Filers
Ansbert Gadicke — 164 joint filings, latest 2026-08-31
Michael Steinmetz — 90 joint filings, latest 2013-02-07
Nicholas Galakatos — 65 joint filings, latest 2013-02-07
Kurt Wheeler — 53 joint filings, latest 2013-02-07
Dennis Henner — 51 joint filings, latest 2012-07-10
Todd Foley — 48 joint filings, latest 2026-08-31
Nicholas J Simon III — 39 joint filings, latest 2013-02-07
MPM Asset Management Investors BV2014 LLC — 38 joint filings, latest 2026-08-31
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HOWL Director 107,429 $1.00 $108.0K -$845.3K 38 2026-07-08
TCR2 THERAPEUTICS INC. (TCRR) Delisted 10%+ Owner 3,745,148 $1.48 $5.54M -$131.9K 1 2023-05-24
Oncorus, Inc. (ONCR) Delisted Director 2,492,843 $0.12 $300.5K $2.27M 3 2022-06-24
iTeos Therapeutics, Inc. (ITOS) Delisted 10%+ Owner 3,377,687 $10.15 $34.28M -$3.52M 2 2021-09-23
TURMERIC ACQUISITION CORP. (TMPMW) Delisted Chief Executive Officer — $0.00 — $0 1 2021-04-30
TURMERIC ACQUISITION CORP. (TMPMU) Delisted Chief Executive Officer 415,500 $9.99 $4.15M $0 1 2020-10-20
Harpoon Therapeutics, Inc. (HARP) Delisted Director 427,595 $23.01 $9.84M $3.50M 4 2020-06-01
SNDX Director 1,138,210 $9.53 $10.84M $0 5 2018-05-25
RYTM 10%+ Owner 2,696,392 $114.02 $307.44M $1.70M 1 2017-10-11
Radius Health, Inc. (RDUS) Delisted 10%+ Owner 3,887,502 $30.00 $116.63M $0 2 2016-09-29
ARATANA THERAPEUTICS, INC. (PETX) Delisted 10%+ Owner 38,386 — — -$12.01M 1 2014-03-12
Epizyme, Inc. (EPZM) Delisted 10%+ Owner 2,413,819 $1.47 $3.55M -$13.65M 1 2014-02-11
ReShape Weightloss Inc. (ETRM) Delisted Director 1,397,699 — — $4.25M 14 2014-01-09
PCRX Director 844,566 $36.45 $30.79M -$33.62M 16 2013-06-13
MBRX Director 105 $8.74 $918 $168.2K 4 2009-06-25
OSCIENT PHARMACEUTICALS CORP (OSCI) Delisted 10%+ Owner 4,222 — — $0 1 2009-05-29
Pharmasset Inc (VRUS) Delisted 10%+ Owner 8,591 — — -$5.77M 4 2008-06-24
PCS 10%+ Owner 837,441 $49.42 $41.39M $0 1 2007-04-26
SENORX INC (SENO) Delisted 10%+ Owner 2,242,379 — — $0 1 2007-04-03
CORNERSTONE THERAPEUTICS INC (CRTX) Delisted 3,853,102 $1.95 $7.51M $0 1 2007-02-15
MEMY 10%+ Owner 11,391,019 $13.01 $148.20M $2.57M 1 2007-01-05

Recent Filings · Page 10 of 11

108 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2009-05-06 ReShape Weightloss Inc. (ETRM) Delisted Grant (A) — $0 EDGAR
2009-02-25 ReShape Weightloss Inc. (ETRM) Delisted Buy (P) +1,765,499 $2.03M EDGAR
2008-07-22 — Disp (D) −3,979,078 $0
2008-06-24 Pharmasset Inc (VRUS) Delisted Sell (S) −28,937 -$576.0K EDGAR
2008-06-23 Pharmasset Inc (VRUS) Delisted Sell (S) −155,800 -$3.10M EDGAR
2008-06-12 MBRX Grant (A) — $0 EDGAR
2008-04-18 MBRX Mixed +316,747 $741.2K EDGAR
2008-03-27 ReShape Weightloss Inc. (ETRM) Delisted Grant (A) — $0 EDGAR
2008-03-24 ReShape Weightloss Inc. (ETRM) Delisted Grant (A) — $0 EDGAR
2008-02-11 Pharmasset Inc (VRUS) Delisted Sell (S) −64,589 -$1.44M EDGAR
Showing 91–100 of 108
Page 10 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.